Sol-Gel Technologies Ltd. Ordinary Shares (SLGL) is a publicly traded Healthcare sector company. As of May 21, 2026, SLGL trades at $65.92 with a market cap of $221.81M and a P/E ratio of 0.00. SLGL moved +0.00% today. Year to date, SLGL is +47.75%; over the trailing twelve months it is +746.27%. Its 52-week range spans $4.01 to $97.97. Analyst consensus is buy with an average price target of $184.00. Rallies surfaces SLGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns SLGL stock?
Hedge funds tracked by Rallies that own SLGL include Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sol-Gel Technologies Ltd. Ordinary Shares.
SLGL Key Metrics
Key financial metrics for SLGL
Metric
Value
Price
$65.92
Market Cap
$221.81M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$97.97
52-Week Low
$4.01
Volume
16
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Top Hedge Funds Holding SLGL
Citadel Advisors holds 12.80K shares of SLGL, changed -67.70% as of Dec 31, 2024.
Hedge funds tracked by Rallies that own SLGL include Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sol-Gel Technologies Ltd. Ordinary Shares.
Does Rallies show 13F holders for SLGL?
Yes. Rallies tracks hedge fund and 13F ownership data for SLGL, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SLGL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SLGL. It does not provide personalized investment advice.
